These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 14550810)
1. Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. Maris M; Boeckh M; Storer B; Dawson M; White K; Keng M; Sandmaier B; Maloney D; Storb R; Storek J Exp Hematol; 2003 Oct; 31(10):941-52. PubMed ID: 14550810 [TBL] [Abstract][Full Text] [Related]
2. Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning. Baron F; Storer B; Maris MB; Storek J; Piette F; Metcalf M; White K; Sandmaier BM; Maloney DG; Storb R; Boeckh M Biol Blood Marrow Transplant; 2006 Nov; 12(11):1176-87. PubMed ID: 17085311 [TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
5. Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation. Nakamae H; Kirby KA; Sandmaier BM; Norasetthada L; Maloney DG; Maris MB; Davis C; Corey L; Storb R; Boeckh M Biol Blood Marrow Transplant; 2009 Jun; 15(6):694-703. PubMed ID: 19450754 [TBL] [Abstract][Full Text] [Related]
6. Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Following Flu-TBI versus TLI-ATG Conditioning. Hannon M; Beguin Y; Ehx G; Servais S; Seidel L; Graux C; Maertens J; Kerre T; Daulne C; de Bock M; Fillet M; Ory A; Willems E; Gothot A; Humblet-Baron S; Baron F Clin Cancer Res; 2015 Jul; 21(14):3131-9. PubMed ID: 25779951 [TBL] [Abstract][Full Text] [Related]
7. A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors. Petersen SL; Ryder LP; Björk P; Madsen HO; Heilmann C; Jacobsen N; Sengeløv H; Vindeløv LL Bone Marrow Transplant; 2003 Jul; 32(1):65-72. PubMed ID: 12815480 [TBL] [Abstract][Full Text] [Related]
9. [Changes of lymphocyte subsets in acute leukemia patients after HLA-mismatched nonmyeloablative hematopoietic stem cell transplantation]. Hu KX; Guo M; Yu CL; Wang DH; Sun QY; Qiao JH; Liu GX; Liu TQ; Ai HS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1527-31. PubMed ID: 20030940 [TBL] [Abstract][Full Text] [Related]
11. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model. Fukuda T; Kerbauy FR; Gooley T; Santos EB; Storb R; Sandmaier BM Transplantation; 2006 Aug; 82(3):332-9. PubMed ID: 16906030 [TBL] [Abstract][Full Text] [Related]
12. Low-dose total-body irradiation and fludarabine followed by hematopoietic cell transplantation from HLA-identical sibling donors do not induce complete T-cell donor engraftment in most patients with progressive hematologic diseases. Fernández-Avilés F; Urbano-Ispizua A; Aymerich M; Rovira M; Martínez C; Talarn C; Jiménez M; Carreras E; Montserrat E Exp Hematol; 2003 Oct; 31(10):934-40. PubMed ID: 14550809 [TBL] [Abstract][Full Text] [Related]
13. Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Willems E; Humblet-Baron S; Dengis O; Seidel L; Beguin Y; Baron F Bone Marrow Transplant; 2010 Sep; 45(9):1442-8. PubMed ID: 20062090 [TBL] [Abstract][Full Text] [Related]
14. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia. Takatu A; Nash RA; Zaucha JM; Little MT; Georges GE; Sale GE; Zellmer E; Kuhr CS; Lothrop CD; Storb R Biol Blood Marrow Transplant; 2003 Nov; 9(11):674-82. PubMed ID: 14652850 [TBL] [Abstract][Full Text] [Related]
15. [Establishment of rhesus model for haploidentical hematopoietic stem cell transplantation with nonmyeloablative conditioning]. Liu LH; Sun QY; Hu KX; Fan CB; Huang YJ; Bian L; Xiao XB; Yao B; Guo M; Yu CL; Ai HS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):677-82. PubMed ID: 16129059 [TBL] [Abstract][Full Text] [Related]
16. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy. Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257 [TBL] [Abstract][Full Text] [Related]
17. Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation. Bosch M; Dhadda M; Hoegh-Petersen M; Liu Y; Hagel LM; Podgorny P; Ugarte-Torres A; Khan FM; Luider J; Auer-Grzesiak I; Mansoor A; Russell JA; Daly A; Stewart DA; Maloney D; Boeckh M; Storek J Cytotherapy; 2012 Nov; 14(10):1258-75. PubMed ID: 22985195 [TBL] [Abstract][Full Text] [Related]
18. High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation. Baron F; Maris MB; Storer BE; Sandmaier BM; Panse JP; Chauncey TR; Sorror M; Little MT; Maloney DG; Storb R; Heimfeld S Leukemia; 2005 May; 19(5):822-8. PubMed ID: 15772701 [TBL] [Abstract][Full Text] [Related]
19. Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant. Feinstein LC; Sandmaier BM; Maloney DG; Maris MB; Gooley TA; Chauncey TR; Hegenbart U; McSweeney PA; Stuart MJ; Forman SJ; Agura EA; Pulsipher MA; Blume KG; Niederwieser DW; Storb RF Biol Blood Marrow Transplant; 2003 Apr; 9(4):266-72. PubMed ID: 12720219 [TBL] [Abstract][Full Text] [Related]
20. Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning. Panse JP; Heimfeld S; Guthrie KA; Maris MB; Maloney DG; Baril BB; Little MT; Chauncey TR; Storer BE; Storb R; Sandmaier BM Br J Haematol; 2005 Mar; 128(5):659-67. PubMed ID: 15725088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]